Skip to main content

Stroke is one of the leading causes of death and disability in Canada.

photos.com

An experimental procedure that stimulates the brain with electrical pulses through the skull may help people recover the ability to speak after suffering a stroke, researchers say.

Up to 30 per cent of stroke survivors are left with a condition called aphasia, in which they have difficulty understanding language, speaking, reading or writing.

In a small study, Canadian and German researchers tested the effects of transcranial magnetic stimulation, or TMS, on patients recovering from a stroke but left with different degrees of aphasia caused by the damage to their brains.

Story continues below advertisement

Twenty-four stroke patients were enrolled in the trial, with 13 getting TMS and 11 treated with a sham procedure. Following the sessions, participants were immediately given speech language therapy.

Patients received 20 minutes of TMS or sham stimulation followed by 45 minutes of speech and language therapy for 10 days, the authors report in the American Heart Association journal Stroke.

"Those who received the real treatment recovered better from their aphasia than those who received the sham treatment," said lead author Dr. Alexander Thiel, director of the stroke unit at Jewish General Hospital in Montreal.

Improvements in the TMS-treated group were about two to three times greater than in the sham-treatment group, he said Thursday from Montreal.

"Even those who received the sham treatment, they also improved, but they didn't improve as much as the others."

TMS is a non-invasive procedure, in which a handheld magnetic coil is applied to the skull, lining up over a specific area on one side of the brain.

The device delivers a low-intensity electrical current, which causes muscles to contract, creating a "tingling, twitching" feeling in the scalp.

Story continues below advertisement

The device is applied to the side of skull where the brain has not been affected by the stroke – in this case on the right side.

"So we try to shut down the unaffected hemisphere so all the therapeutic effort would go to the affected hemisphere," said Thiel, explaining that the effects of TMS last about 30 to 45 minutes, during which time patients undergo speech-language therapy.

The idea is to shut down the right side to force the weakened left side of the brain – particularly the areas involved in speech – to do all the work of relearning language, he said. The mental exercise also may prompt the brain to form new connections, a phenomenon known as neuroplasticity.

Not all stroke survivors with aphasia could be treated with the electrical stimulation technique.

People who have seizures or wear a pacemaker would not be candidates, and anyone with complete speech loss would likely not benefit, he pointed out.

The small trial is a proof-of-concept study, which shows TMS was safe for patients and appeared to have benefit in overcoming aphasia more quickly. But more research is needed to definitively prove its effectiveness, Thiel stressed.

Story continues below advertisement

In October, the scientists will begin an international, multicentred trial of TMS with about 100 stroke patients. Dubbed NORTHSTAR, the study will include three Canadian centres – two in Montreal and one in Toronto.

The researchers want to get patients into the study as early as possible following a stroke, ideally about a month after the event. That's because genes that kick into gear to form new connections in the brain peak about two to three weeks after a stroke, he said.

"We think that there is a window of opportunity where these kinds of therapies are especially effective."

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter